- Home
- PRLD vs PAYS Comparison
PRLD vs PAYS Comparison
Compare PRLD & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLD | PAYS |
|---|---|---|
| Founded | 2016 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 346.5M | 375.7M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PRLD | PAYS |
|---|---|---|
| Price | $4.89 | $8.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $5.67 | ★ $9.42 |
| AVG Volume (30 Days) | 525.3K | ★ 591.7K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.21 | ★ 85.71 |
| EPS | N/A | ★ 0.09 |
| Revenue | $12,140,000.00 | ★ $24,120,434.00 |
| Revenue This Year | $320.10 | $33.83 |
| Revenue Next Year | $100.00 | $14.89 |
| P/E Ratio | ★ N/A | $95.11 |
| Revenue Growth | ★ 73.43 | N/A |
| 52 Week Low | $0.75 | $3.08 |
| 52 Week High | $5.69 | $8.88 |
Technical Indicators
Market Signals| Indicator | PRLD | PAYS |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 64.85 |
| Support Level | $3.92 | $5.01 |
| Resistance Level | $5.43 | N/A |
| Average True Range (ATR) | 0.44 | 0.42 |
| MACD | 0.09 | 0.10 |
| Stochastic Oscillator | 52.33 | 82.93 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.